The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial.
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Innovent Biologics
Speakers' Bureau - AstraZeneca; BeiGene; HenRui; Innovent Biologics; Roche China
Research Funding - Akeso Biopharma; AstraZeneca; Bristol-Myers Squibb; Chia Tai Tianqing Pharmaceutical Group; Junshi Pharmaceuticals; QiLu Pharmaceutical
 
Wenfeng Fang
No Relationships to Disclose
 
Yuanyuan Zhao
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Runxiang Yang
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Zhiyong He
No Relationships to Disclose
 
Hui Zhao
No Relationships to Disclose
 
Mingjun Li
No Relationships to Disclose
 
Kai Li
No Relationships to Disclose
 
Qibin Song
No Relationships to Disclose
 
Xiaobo Du
No Relationships to Disclose
 
Yulan Sun
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Zhiyu Wang
No Relationships to Disclose
 
Kunning Yang
No Relationships to Disclose
 
Yun Fan
No Relationships to Disclose
 
Wenting Li
Employment - 12.Akeso Biopharma, Inc., Zhongshan, China
 
Yu Xia
Employment - 12.Akeso Biopharma, Inc., Zhongshan, China
Leadership - 12.Akeso Biopharma, Inc., Zhongshan, China
Stock and Other Ownership Interests - 12.Akeso Biopharma, Inc., Zhongshan, China